4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tevogen Bio Holdings Inc. (TVGN) operates in the Biotechnology industry and is headquartered in Warren, United States with about 18 employees. Its market capitalization is roughly $24 million. In the fiscal year ended 2025-12-31, TVGN reported $0M in revenue and ($26M) in net income.
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($26M) | ($54M) | ($9M) | ($1M) | — |
| Net Income | ($26M) | ($14M) | ($60M) | $4M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($5M) | ($5M) | ($6M) | ($5M) | ($10M) | — |
| Net Income | ($5M) | ($5M) | ($6M) | ($6M) | ($10M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $4M | $4M | $6M | $357M |
| Total Liabilities | $13M | $10M | $100M | $15M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TVGN viewer.
About TickerBase · Data methodology & sources